Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2004, p. 5324-5331, Vol. 24, No. 12
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.12.5324-5331.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Pathology, Stanford University School of Medicine, Stanford, California 94305,1 Institute of Genetic Medicine, Cornell University Weill Medical School, New York, New York 10021,2 Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905,3 Deutsches Krebsforchungszentrum, Angewandte Tumorvirologie, 69120 Heidelberg, Germany,4 Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 381055
Received 31 October 2003/ Returned for modification 8 December 2003/ Accepted 18 March 2004
|
|
|---|
|
|
|---|
Biochemical studies have demonstrated that Pbx proteins interact with a subset of Hox proteins to enhance their DNA binding affinities and specificities (6-9, 16, 19, 24-26, 37, 38). Pbx proteins also heterodimerize with the Meis/Prep subfamily of TALE-class homeodomain proteins (4, 8, 14) to form trimeric complexes with Hox proteins on appropriate DNA sites (3, 4, 12, 33) that regulate developmental gene expression. Pbx proteins are highly similar to each other and share extensive sequence identity within and flanking their DNA binding homeodomains. Additional isoforms of mammalian Pbx proteins arise from differential splicing of Pbx transcripts to yield high-molecular-weight (MW) (Pbx1a, Pbx2, Pbx3a, and Pbx4) and low-MW (Pbx1b and Pbx3b) forms of the respective proteins (22, 40). Although the DNA binding properties of Pbx proteins appear similar in vitro, the transcriptional effector properties of various isoforms can be distinguished on the basis of differential recruitment of transcriptional cofactors (2).
In contrast to their well-characterized roles as transcription factors, the differential contributions of Pbx proteins during mammalian development and organogenesis have not been fully determined. To assess their functional roles in vivo and their possible overlapping and unique contributions, we have generated and characterized mice deficient for each of the Pbx1, -2, and -3 proteins. Our previous studies demonstrated that Pbx1 and Pbx3 have unique, essential functions required for embryonic development and postnatal survival, respectively. Pbx1-deficient embryos die at gestational day 15 or 16 with severe hypoplasia or aplasia of multiple organs (15, 32, 34, 36), as well as homeotic transformation (36) and hematopoietic abnormalities (11). Mice deficient for Pbx3 develop to term but die within a few hours of birth due to central respiratory failure (J. Rhee, A. Arata, L. Selleri, Y. Jacobs, S. Arata, H. Onimaru, and M. Cleary, submitted for publication). In this study, we demonstrated that, despite widespread embryonic expression, Pbx2 is not an essential gene, whose loss does not affect normal development, organogenesis, fertility, hematopoiesis, or immune function, likely due to redundancy with the related Pbx family members.
|
|
|---|
![]() View larger version (31K): [in a new window] |
FIG. 2. Targeted inactivation of Pbx2 and Southern, Northern, and Western analyses of wt and mutant mice. (A) Schematic representation of the mouse Pbx2 genomic locus, targeting vector, and mutated allele following homologous recombination. Approximately 16 kb of the Pbx2 locus flanking exon 3 (black box) are depicted along with mapped restriction sites. The targeting construct carries a PGK-neo cassette (shaded box) inserted into the unique SacI site of Pbx2 exon 3, and the herpes simplex virus thymidine kinase gene (HSV-TK) (white box). The transcriptional orientations of the Pbx2 arms of homology are opposite to that of the PGK-neo cassette. The 5' and 3' external probes used for Southern blot analyses are shown as solid black boxes below the mutated allele. Restriction enzyme sites: E, EcoRI; Nhe, NheI; Sal, SalI; Xba, XbaI; Xho, XhoI. An EcoRI site (italicized) was introduced to facilitate diagnostic analysis. (B) Southern blot analysis of Pbx2 alleles. DNA from mouse tissues was analyzed with the probe and enzyme indicated beneath the panel. wt (5.5 kb) and mutant (6.5 kb) Pbx2 alleles are indicated to the right of the panel. (C and D) Western blot analysis of Pbx2 expression. Protein extracts were subjected to Western blot analysis using a monoclonal antibody specific for all Pbx long isoforms ( -PbxL) and a Pbx2-specific polyclonal antibody raised against a peptide mapping at the amino terminus of Pbx2 ( -Pbx2 in panel D). Smaller bands, of less than 50 kDa, are present in both wt and Pbx2/ livers and represent nonspecific cross-reactivity by this antibody (D). Genotypes determined by Southern blotting are listed at the top. The left lane of panel C contains in vitro-translated Pbx2. (E) Northern blot analysis of Pbx2 expression. Poly(A)+ RNAs from E17 embryos were hybridized with a probe specific for the Pbx2 3' UTR. (Left panel) No Pbx2 transcripts are present in Pbx2/ embryos, in contrast to the 3.2-kb wt transcripts (as previously reported [22]) detected in Pbx2+/+ embryos. (Right panel) Methylene blue staining indicates equal amounts of 28S and 18S rRNAs in each lane.
|
Western blot analysis.
Embryonic tissues (E17), thymocytes, or adult bone marrow cells were lysed in 2x SDS sample buffer following homogenization using established procedures (12). Proteins were subjected to SDS-polyacrylamide gel electrophoresis and immobilized on nitrocellulose filters following electrophoretic transfer. Filters were probed with a murine monoclonal antibody that recognizes all three Pbx high-MW isoforms (
-PbxL) or monoclonal antibodies specific for Pbx1a or Pbx3a. A Pbx2 affinity-purified rabbit polyclonal antibody raised against a peptide mapping at the amino terminus of Pbx2 was also used (Santa Cruz Biotechnology, Inc.). Immune complexes were detected by using a horseradish peroxidase-conjugated secondary antibody and an enhanced luminescence system (ECL; Amersham Pharmacia Biotech, Inc., Piscataway, N.J.).
Histology. For histological analysis, embryos were fixed in formalin and embedded in paraffin for sectioning using standard procedures (35). Sections of 5 µm thickness were stained with hematoxylin and eosin, mounted in distrene plasticizer xylene, and photographed.
Skeletal preparations. Differential staining of cartilage and bone in whole mouse embryos (E16) and newborn mice was visualized with alcian blue and alizarin red (10, 21)
Whole-mount and section in situ hybridizations. Whole-mount in situ hybridizations were performed on embryos at E9.5 and E10.5 as previously described (43). In situ hybridizations were performed on frozen sections, generated from wild-type (wt) embryos at E13.5 and E15.5, as previously described (43). Single-stranded sense and antisense riboprobes specific for the Pbx2 cDNA were generated and hybridized to frozen sections containing all developing organs in order to establish Pbx2 expression patterns in later stages of murine development. The Pbx2 hybridization probe was composed of approximately 650 bp of 3' UTR as described above. Probes were labeled with digoxigenin, using standard procedures (42). Images were obtained using an Olympus BX41 compound light microscope and digital camera or an Olympus SZX12 dissection microscope.
Real-time quantitative RT-PCR. For reverse transcription-PCR (RT-PCR) total RNA was isolated from E17.5 tissues by using Trizol reagent (Gibco BRL) and treated with DNase Treatment and Removal Reagent (DNA-free; Ambion). RNA was reverse transcribed by using the High Capacity cDNA Archive kit (Applied Biosystems, Foster City, Calif.), using random primers for initiating cDNA synthesis. TaqMan real-time quantitative PCR assays were performed on a Perkin-Elmer ABI PRISM 7700 sequence detection system, using SDS version 1.9 software (Applied Biosystems). Specific primers and fluorogenic TaqMan probes were custom designed using the Assay by Design Service (Applied Biosystems). Primers, probes, and PCR conditions are available upon request.
Hematologic studies. Blood (50 to 100 µl) from the tail vein was collected in an EDTA-coated tube, and automated blood counts were performed using a Coulter cytometer.
Immunological studies. Freshly isolated cells from bone marrow and thymus were stained for four-color analysis, and the fluorescence was analyzed by using a dual-laser FACS Vantage system (Becton Dickinson Immunocytometry Systems, Mountain View, Calif.) with a four-decade logarithmic amplifier. Dead cells were detected by staining with propidium iodide (1 µg/ml) and gated out electronically. Residual erythrocytes were also gated out electronically. All antibodies were purchased from BD Pharmingen (San Diego, Calif.). Specificities of antibodies were as follows: phycoerythrin-conjugated RM4-5 (anti-CD4), biotinylated 53-6.7 (anti-CD8a), fluorescein isothiocyanate-conjugated S7 (anti-CD43), and allophycocyanin-conjugated RA3-6B2 (anti-B220).
Mice were immunized by intraperitoneal injection of 100 µg of 2,4-dinitrophenol (DNP) conjugated to keyhole limpet hemocyanin (DNP-KLH) with complete Freund's adjuvant, as described previously (31). The titers of anti-DNP antibodies were measured by enzyme-linked immunosorbent assay using DNP-conjugated bovine albumin (DNP-albumin) as the capture antigen, alkaline phosphatase-conjugated rabbit anti-mouse immunoglobulin G (IgG) or IgM as the secondary antibody, and Sigma Fast p-nitrophenyl phosphate as the substrate for alkaline phosphatase. Absorbances (405 nm) of pre- and postimmune sera were compared to monitor immune responses against the hapten.
|
|
|---|
![]() View larger version (116K): [in a new window] |
FIG. 1. Pbx2 expression during mouse development. (A) In situ hybridizations were performed on frozen sagittal sections of E15.5 embryos (unless noted otherwise) as shown. (B to D) Pbx2 is expressed in the telencephalon, specifically in the neocortex (ncx), including the ventricular and subventricular zones, the hippocampus (h), and the developing striatum (s) and globus pallidus. The black arrowhead in panel C indicates the lateral ventricle. (D) In the mesenchephalon, Pbx2 expression is particularly prominent in the roof of the midbrain (rm) and in the choroid plexus (cp). The black arrowhead indicates the mesencephalic vesicle. (E) Pbx2 expression in the epidermal layer of the developing skin (as denoted by the black arrowhead in the inset) and in the developing vibrissae, where expression is limited to the root sheath (arrows) but is not evident in the surrounding mesenchyme. (F) Pbx2 is highly expressed in the olfactory epithelium, as indicated by arrows. The arrowhead indicates the nasal cavity (inset). (G) Pbx2 is expressed in the epithelium lining the cochlear ducts (c), in the trigeminal ganglion (arrow), in the epithelium of the tubotympanic recess (black arrowhead), and in the submandibular glands (sg). (H) Pbx2 expression is marked in the second cervical dorsal root ganglion (drg) and in the chondrocytes of the body of the second cervical vertebra (C2). Black arrowheads depict spinal nerves and their roots. (I) Pbx2 expression at E13.5 is predominant in the respiratory epithelium lining the segmental bronchi (arrows) of the lung (lg). Little to no expression of Pbx2 is detected in the mesenchyme of the lung or in the mesothelial lining of the pericardial cavity (pc). (J) Pbx2 is markedly expressed in distinct areas of the gut (g), specifically in the epithelium (arrow) covering the lumina (l, inset) and in the muscularis propria (black arrowhead). (K) Pbx2 is expressed in the developing dorsal pancreas (dp), specifically in the epithelium of the pancreatic acini (arrows) and ducts. (L) Pbx2 is expressed in the cortical (cx) and medullary (mr) kidney (k), in particular in the epithelium lining the collecting ducts (black arrowheads) and in the glomeruli (arrows). Little to no expression of Pbx2 is detected in the nephrogenic mesenchyme. Image B was obtained using a dissection microscope and digital camera, images E to J and L were photographed using a light microscope at a power of x4. Image K and insets E, F, and L are at a magnification of x10, while the inset of image J is at a magnification of x40. All images were digitally processed.
|
In sum, in early mouse development Pbx2 expression is widespread, comparable to the ubiquitous Pbx2 expression during the first hours of zebra fish development (41). Later in mouse development, Pbx2 expression becomes more restricted and mostly preponderant in epithelial and neural tissues, comparable to expression patterns of the Drosophila homolog Exd (29). Conversely, Pbx2 is expressed at very low levels or is undetectable in the mesenchymal components of most tissues and organ systems, in contrast to Pbx1, which is highly expressed in mesenchymal and mesodermal cells (35).
Pbx2 is not essential for fetal and postnatal survival. Mice with targeted disruption of Pbx2 were generated to determine whether the wide expression of Pbx2 during murine embryogenesis reflected a major role for its encoded protein in development. A null allele of the endogenous mouse Pbx2 gene was created by deletion of the entire third exon and insertion of a neomycin resistance gene through homologous recombination in ES cells (Fig. 2A). Exon 3 was chosen for targeting since: (i) it is the largest Pbx2 5' exon (other than exon 1), whose disruption allows a truncation of Pbx2 immediately downstream of the initiating methionine to minimize possible expression of a truncated protein with dominant-negative properties; (ii) it lacks a unit number of codons, thereby minimizing the generation of a protein product with an in-frame deletion retaining partial or complete function, due to splicing around the targeted exon; and (iii) it codes for a portion of Pbx2 that is highly conserved in humans, mice, and flies. Exon 1 was not targeted since no information was available regarding possible alternative initiation sites downstream of exon 1, within the first intron. Overall, the above-described strategy proved successful, as a complete knockout of Pbx2 was obtained (Fig. 2).
The expected wt and mutated Pbx2 alleles were observed by Southern blot analysis of DNA extracted from targeted ES cell lines (results not shown) and mouse tissues (Fig. 2B). Western blot analysis of postnatal thymocytes and bone marrow cells showed that homozygous mutant mice did not produce Pbx2 protein, the only high-MW-isoform Pbx protein detectable in these tissues (Fig. 2C). Furthermore, Western blot analysis of fetal livers at E16.5 with a Pbx2-specific antibody raised against a peptide mapping at the amino terminus of Pbx2 clearly demonstrated that homozygous mutant mice did not produce full-length (50 kDa) or truncated forms of Pbx2 (Fig. 2D). Northern blot analysis was performed to exclude the possibility that a mutant Pbx2 protein, not detectable by Western blot analysis, might be produced from an altered transcript encoded by the targeted Pbx2 gene. This analysis demonstrated the absence of either full-length or truncated Pbx2 transcripts in Pbx2/ embryos (Fig. 2E). Pbx2/ mice were viable, with binomial proportion analysis showing no deviations from a 2:1 ratio of heterozygote to wt or heterozygote to homozygous mutant (data not shown). The sizes and body weights of Pbx2/ mice were indistinguishable from those of their wt littermates (18.68 ± 1.25 g and 18.35 ± 1.34 g, respectively), as was their longevity and fertility (data not shown). The normal survival of Pbx2/ mice suggested that Pbx2 is not solely or primarily responsible for any processes that are critical for development or survival.
Pbx2 is not essential for organogenesis. Although lack of Pbx2 was compatible with life, this did not rule out possible subtle effects on organ structure. Major internal organs of Pbx2/ newborn mice and their wt littermates were examined grossly and by histology. No structural or morphological abnormalities of internal organs were observed in Pbx2/ mice (lung, liver, spleen, and kidney of wt and Pbx2/ mice are shown in Fig. 3). Furthermore, cartilage/skeletal preparations of Pbx2/ embryos and newborn mice showed neither gross nor subtle defects in cartilaginous and skeletal development (data not shown). These data demonstrate that lack of Pbx2 expression has no detectable effect on the morphogenesis of organs in which it is normally expressed.
![]() View larger version (92K): [in a new window] |
FIG. 3. Histological analysis of major organs of wt and Pbx2/ newborn mice. Formalin-fixed, paraffin-embedded tissue sections of various organs (indicated to the left) of adult wt and Pbx2/ littermates were stained with hematoxylin and eosin and photographed using a light microscope. Magnifications: lung, liver, and kidney, x10; spleen, x4; insets, x20. All images were digitally processed.
|
-PbxL) that recognizes a Pbx2 epitope shared with the high-MW isoforms of Pbx1 and Pbx3 (Pbx1a and Pbx3a, respectively) but not present in the low-MW isoforms Pbx1b or Pbx3b (Pbx2 has no low-MW isoform). In most tissues examined from embryos at E17.5, there were no differences in the abundance of the high-MW-isoform Pbx proteins in Pbx2/ embryos as compared to wt embryos (Fig. 4A). A modest decrease was observed in fetal thymus, brain, and liver (Fig. 4A). The general lack of (or minimal) decrease in Pbx proteins detected with this antibody in tissues of Pbx2/ embryos suggested that Pbx2 is not the preponderant Pbx protein expressed in these tissues during embryogenesis. Furthermore, tissues and organs such as the developing brain, where Pbx2 is highly expressed, as demonstrated by in situ hybridization (Fig. 1), were not affected either morphologically or functionally by its loss. Quantitative real-time RT-PCR showed that transcripts for other high-MW Pbx isoforms (Pbx1a and Pbx3a) were expressed in developing brain and other tissues (Fig. 4B and C), but there was no evidence of compensatory increases in their levels in Pbx2/ compared to wt embryos. Taken together, these observations suggested that normal organ development and survival of Pbx2/ mice is likely to result from functional compensation by other Pbx proteins. Interestingly, it has been reported that in zebra fish the Pbx genes are functionally equivalent in that each one, when overexpressed, can efficiently rescue the lazarus/Pbx4 mutant phenotype (41).
![]() View larger version (33K): [in a new window] |
FIG. 4. Western blot and quantitative RT-PCR analysis of Pbx expression. (A) Protein extracts prepared from various tissues (indicated at the top) of E17.5 embryos were analyzed by Western blotting using a monoclonal antibody specific for all Pbx long-form proteins ( -PbxL). (B and C) Quantitative RT-PCR analysis of Pbx1a and Pbx3a expression. Total RNA was isolated from the indicated tissues of E17.5 wt (black bars) and Pbx2/ (grey bars) embryos. Bars (means ± standard deviations) indicate numbers of transcripts normalized against 105 ß-actin transcripts.
|
|
View this table: [in a new window] |
TABLE 1. Hematological parameters of Pbx2-deficient mice
|
![]() View larger version (30K): [in a new window] |
FIG. 5. Immunological studies of Pbx2/ mice. Fluorescence-activated cell sorter analyses of bone marrow cells (A) and thymocytes (B) of wt and Pbx2/ littermates demonstrated no detectable differences in lymphoid cell subsets. (C) IgG levels were comparable in the sera of wt and Pbx2/ littermates before and after immunization with the hapten DNP conjugated to KLH.
|
Two models for mammalian Pbx protein function can be envisioned for conceptualizing the role of multiple Pbx isoforms and the divergent phenotypes induced by their absence. In a quantitative model, the various Pbx protein isoforms may be largely redundant, but with a requirement to maintain a critical threshold of Pbx protein concentration, regardless of isotype, necessary for normal development. This scenario would be comparable to Pbx function in zebra fish, where the Pbx proteins are functionally equivalent (41) and is also supported by preliminary results indicating that Pbx1/Pbx2+/ compound mutant embryos die in utero at E13.5, earlier than Pbx1/ embryos, which succumb at E15/16 (T. Capellini and L. Selleri, unpublished observations). Since our immunoblot analyses indicated that Pbx2 does not seem to be the preponderant Pbx protein in most tissues during embryonic development, its absence would not substantially reduce the total Pbx protein levels below the necessary threshold, thus accounting for the lack of measurable phenotypes. Alternatively, in a qualitative model, various Pbx isoforms (high versus low MW) may display different functional properties, consistent with in vitro biochemical studies of their divergent transcriptional effector properties (2). However, our analyses indicate that Pbx2 null mice lack detectable phenotypes attributable to deficiencies in tissues (thymus and adult bone marrow) that express Pbx2 as the only high-MW Pbx isoform protein. Since these tissues also express low-MW Pbx isoforms, such as Pbx1b, they may be able to functionally replace Pbx2. The alternative possibility that Pbx protein function is simply not required for postnatal hematopoietic and immune function has not been conclusively ruled out since Pbx1- and Pbx3-deficient mice die in utero or in the immediate postnatal period, respectively (Rhee et al., submitted; 36). Our results are most consistent with a quantitative model of mammalian Pbx protein function, but elucidation of the potential interrelationships and overlapping functions of Pbx family proteins in different developmental pathways will require detailed characterization of various organ systems in compound null mice.
These studies were supported by grants to M.L.C. from the National Institutes of Health (CA42971, CA70704, and CA90735) and to L.S. from the March of Dimes and Birth Defects Foundation (6-FY03-071) and the National Institutes of Health (HD043997-01 A1).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»